Table 3 Comparison of clinical outcomes in the KI-BCI group, tDCS group, and tDCS-BCI group.
Variable/group | Pre-intervention | Post-intervention | Main effect (Time) F(p) | Main effect (Group) F(p) | Interaction effect (Time*Group) F(p) |
|---|---|---|---|---|---|
FMA-UE | |||||
KI-BCI | 22.00 ± 0.49 | 40.50 ± 0.86a | 391.500 (0.001)* | 0.516 (0.603) | 11.596 (0.001)* |
tDCS | 22.29 ± 1.75 | 33.93 ± 1.64ab | |||
BCI-tDCS | 22.57 ± 3.26 | 36.50 ± 4.07a | |||
MSS | |||||
KI-BCI | 37.14 ± 0.65 | 58.57 ± 0.98a | 560.419 (0.001)* | 6.609 (0.005)* | 8.445 (0.001)* |
tDCS | 36.71 ± 0.79 | 51.86 ± 1.36ab | |||
BCI-tDCS | 38.21 ± 1.04 | 57.93 ± 1.23ac | |||
ARAT | |||||
KI-BCI | 15.93 ± 2.33 | 26.50 ± 2.94a | 93.450 (0.001)* | 0.568 (0.573) | 10.995 (0.001)* |
tDCS | 15.07 ± 2.22 | 19.71 ± 2.09a | |||
BCI-tDCS | 12.93 ± 2.65 | 25.93 ± 3.81a | |||
MBI | |||||
KI-BCI | 33.86 ± 0.85 | 62.86 ± 0.90a | 761.997 (0.001)* | 1.089 (0.334) | 11.024 (0.001)* |
tDCS | 35.21 ± 1.84 | 55.00 ± 2.14ab | |||
BCI-tDCS | 34.79 ± 1.66 | 59.79 ± 2.08a | |||